Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy

SUPPORTIVE CARE IN CANCER

Volume 28, Issue 12, Pages 5597-5599

SPRINGER

Immune checkpoint inhibitors; Immunotherapy; Skin toxicity; Adverse events; Management

Oncology Health Care Sciences & Services Rehabilitation